MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1.
MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by targeting ABCB1.
复制标题
MicroRNA-595 通过靶向 ABCB1 使卵巢癌细胞对顺铂敏感
DOI:
10.18632/oncotarget.13526
复制
发表时间:
2016-12-27
期刊:
影响因子:
--
通讯作者:
Lou G
中科院分区:
文献类型:
--
作者:
Tian S;Zhang M;Chen X;Liu Y;Lou G
Ovarian cancer is among the leading cause of cancer-related deaths in females. In this study, we demonstrated that miR-595 expression was downregulated in the ovarian cancer tissues and cell lines. miR-595 expression was lower in the lymph node metastases tissues than in the primary ovarian cancer tissues and normal tissues. Furthermore, miR-595 overexpression suppressed the ovarian cancer cell proliferation, colony formation and invasion and promoted the sensitivity of ovarian cancer cell to cisplatin. We identified ABCB1 as a direct target gene of miR-595 in the ovarian cancer cell. ABCB1 expression was upregulated in the ovarian cancer tissues and cell lines. Morevoer, the expression level of ABCB1 was inversely correlated with miR-595 in the ovarian cancer tissues. In addition, overexpression of ABCB1 decreased the miR-595-overexpressing HO8910PM and SKOV-3 cell sensitivity to cisplatin. Ectopic expression of ABCB1 promoted the miR-595-overexpressing HO8910PM and SKOV-3 cell proliferation, colony formation and invasion. These data suggested that miR-595 acted a tumor suppressor role in ovarian cancer development and increased the sensitivity of ovarian cancer to cisplatin.